Vicarious Surgical Inc.
$ 0.70
0.00%
15 Apr - close price
- Market Cap 5,058,200 USD
- Current Price $ 0.70
- High / Low $ 0.87 / 0.65
- Stock P/E N/A
- Book Value 1.38
- EPS -8.19
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.73 %
- ROE -1.77 %
- 52 Week High 13.75
- 52 Week Low 0.27
About
Vicarious Surgical Inc. (RBOT) is a cutting-edge medical technology company revolutionizing surgical practices with its advanced robotic surgical systems designed to enhance precision and improve patient outcomes. By leveraging a proprietary platform that integrates advanced robotics and artificial intelligence, the company is at the forefront of the minimally invasive surgery movement, equipping surgeons with unmatched dexterity, visualization, and control. Vicarious Surgical not only aims to boost surgical efficiency but also to significantly reduce patient recovery times, addressing the rising demand for robotic-assisted procedures in an evolving healthcare landscape. As a prominent player in the burgeoning surgical robotics market, Vicarious Surgical is committed to driving innovation and improving patient care.
Analyst Target Price
$5.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-12-31 | 2025-11-12 | 2025-08-12 | 2025-04-28 | 2025-03-03 | 2024-11-12 | 2024-08-12 | 2024-04-29 | 2024-03-04 | 2023-11-13 | 2023-07-27 | 2023-05-08 |
| Reported EPS | -1.65 | -1.91 | -2.23 | -2.58 | -2.43 | -2.87 | -2.59 | -0.1 | -0.06 | -0.1 | -0.12 | -0.21 |
| Estimated EPS | -1.37 | -0.14 | -0.14 | -2.48 | -2.69 | -2.55 | -2.77 | -0.09 | -0.12 | -0.14 | -0.14 | -0.13 |
| Surprise | -0.28 | -1.77 | -2.09 | -0.1 | 0.26 | -0.32 | 0.18 | -0.01 | 0.06 | 0.04 | 0.02 | -0.08 |
| Surprise Percentage | -20.438% | -1264.2857% | -1492.8571% | -4.0323% | 9.6654% | -12.549% | 6.4982% | -11.1111% | 50% | 28.5714% | 14.2857% | -61.5385% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: RBOT
2026-04-09 03:41:15
Vicarious Surgical Inc. stockholders approved a proposal to amend the Company's Certificate of Incorporation to effect a reverse stock split. The Board of Directors will determine the exact ratio, which can range from 1-for-2 to 1-for-30, and the timing of the split. This action is typically taken to raise the per-share price, potentially to meet exchange listing requirements or attract institutional investors, and was signed off by CEO Stephen From on April 8, 2026.
2026-04-08 20:41:15
Vicarious Surgical Inc. (RBOT) stockholders have approved an amendment to the company's Certificate of Incorporation, authorizing a reverse stock split for its Class A and Class B common stock. The approved ratio range is between 1-for-2 and 1-for-30, with the exact ratio to be determined by the Board. This decision, backed by a significant majority of votes, grants the Board flexibility to adjust the company's share count and price structure.
2026-04-06 23:09:48
Innovation Endeavors III and managing partner Dror Berman have reduced their beneficial ownership in Vicarious Surgical Inc. (RBOT) Class A common stock to 3.4%, holding 221,038 shares. This change follows a series of open market sales executed between March 20 and April 6, 2026, at weighted average prices ranging from $0.70 to $1.06 per share. As a result of these transactions, Innovation Endeavors ceased to be a beneficial owner of more than five percent of the Class A common stock on April 6, 2026.
2026-03-26 01:08:42
Vicarious Surgical Inc. (OTCQB: RBOT) announced its Class A common stock has begun trading on the OTCQB Venture Market, a move that the company expects will improve market visibility. The surgical robotics company aims for a potential listing on the Nasdaq Capital Market and targets a design freeze by the end of 2026. Despite a "WEAK" financial health score from InvestingPro and an EBITDA loss of $49.54 million over the last year, analysts maintain a $5 price target for the stock, suggesting significant upside.
2026-03-25 20:39:02
Vicarious Surgical Inc. has announced its Class A common stock has begun quotation on the OTCQB® Venture Market under the ticker symbol RBOT, effective March 24, 2026. This move is a strategic step towards a potential future listing on the Nasdaq Capital Market, aiming to enhance market visibility and trading liquidity. The company is advancing its next-generation robotics technology for minimally invasive surgery and is working towards a design freeze by the end of 2026.
2026-03-25 20:20:00
Vicarious Surgical Inc. (OTCQB: RBOT) has upgraded its stock trading to the OTCQB Venture Market to enhance market visibility and facilitate greater market maker participation. The surgical robotics company's stock currently trades at $0.90, representing an 88% decline over the past year, with a market capitalization of $6.41 million. Despite a "WEAK" financial health score from InvestingPro and an EBITDA loss of $49.54 million, analysts maintain a $5 price target, suggesting significant upside potential as the company works toward a Nasdaq listing and a design freeze by the end of 2026 for its surgical robotics technology.
